<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2022-6-47-52</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-2564</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Биомаркеры неспецифического воспаления и атеросклероза сонных артерий при синдроме обструктивного апноэ сна</article-title><trans-title-group xml:lang="en"><trans-title>Biomarkers of non-specific inflammation and atherosclerosis of carotid arteries in obstructive sleep apnea syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0574-8064</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полонский</surname><given-names>Е. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Polonskiy</surname><given-names>E. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Полонский Евгений Львович, врач невролог отделения клинической неврологии отдела клинической неврологии и медицины сна</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Polonsky Evgeniy L., neurologist of Dept of Clinical Neurology, Dept of Clinical Neurology and Sleep Medicine</p><p>Saint Petersburg</p></bio><email xlink:type="simple">limbuss1@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5422-2878</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зыбина</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zybina</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зыбина Наталья Николаевна, д.б.н., проф., зав. отделом лабораторной диагностики</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Zybina Natalia N., Dr Bio Sci, professor, head of Dept of Clinical Laboratory Diagnostics</p><p>Saint Petersburg</p></bio><email xlink:type="simple">zybinan@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4722-0900</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тихомирова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tikhomirova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тихомирова Ольга Викторовна, д.м.н., доцент, зав. отделом клинической неврологии и медицины сна</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Tikhomirova Olga V., DM Sci (habil.), associate professor, head of Dept of Clinical Neurology and Sleep Medicine</p><p>Saint Petersburg</p></bio><email xlink:type="simple">Olvitikhomirova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6411-1402</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ломова</surname><given-names>И. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Lomova</surname><given-names>I. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ломова Ирина Павловна, к.м.н., с.н.с. НИЛ цереброваскулярной патологии научноисследовательского центра</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Lomova Irina P., PhD Med, senior research of Cerebrovascular Disease Laboratory</p><p>Saint Petersburg</p></bio><email xlink:type="simple">irpalo@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Всероссийский центр экстренной и радиационной медицины имени А.М. Никифорова» МЧС России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>All-Russian Centre for Emergency and Radiation Medicine n.a. A.M. Nikiforov</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>22</day><month>04</month><year>2022</year></pub-date><volume>1</volume><issue>6</issue><issue-title>Современная лаборатория (1)</issue-title><fpage>47</fpage><lpage>52</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Полонский Е.Л., Зыбина Н.Н., Тихомирова О.В., Ломова И.П., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Полонский Е.Л., Зыбина Н.Н., Тихомирова О.В., Ломова И.П.</copyright-holder><copyright-holder xml:lang="en">Polonskiy E.L., Zybina N.N., Tikhomirova O.V., Lomova I.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/2564">https://www.med-alphabet.com/jour/article/view/2564</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Выявление значимых лабораторных маркеров развития атеросклероза (АС) сонных артерий (СА) у пациентов с синдромом обструктивного апноэ (СОАС).</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Обследовано 152 пациента мужского пола, у 84 из которых, по данным полисомнографии (ПСГ), диагностирован СОАС. Диагностику АС СА проводили методом триплексного сканирования (ТС). Комплекс лабораторных исследований включал оценку показателей липидного обмена, концентрации высокочувствительного С-реактивного белка (вчСРБ), интерлейкина‑1β (ИЛ‑1β), интерлейкина‑6 (ИЛ‑6) и интерлейкина‑10 (ИЛ‑10) в сыворотке крови.</p></sec><sec><title>Результаты</title><p>Результаты. У пациентов с СОАС обнаружено статистически значимое увеличение комплекса проатерогенных факторов: вчСРБ, провоспалительных цитокинов, соотношения апобелков и коэффициента атерогенности по сравнению с пациентами без СОАС не смотря на отсутствие различий по выраженности атеросклеротического поражения сонных артерий в этих группах.</p></sec><sec><title>Заключение</title><p>Заключение. Развитие СОАС ассоциировано с выраженными нарушениями липидного обмена и активацией неспецифического воспаления, что определяет повышенный риск развития атеросклероза в данной группке пациентов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose of study</title><p>Purpose of study. Identification of significant laboratory markers for the development of atherosclerosis (AS) of the carotid arteries (CA) in patients with obstructive sleep apnea syndrome (OSAS).</p></sec><sec><title>Materials and methods</title><p>Materials and methods. 152 male patients were examined, 84 of whom, according to polysomnography (PSG), were diagnosed with OSAS. Diagnosis of AS CA was performed by triplex scanning. The complex of laboratory studies included the assessment of lipid metabolism, the concentration of highly sensitive C-reactive protein (hsCRP), interleukin‑1β (IL‑1β), interleukin‑6 (IL‑6) and interleukin‑10 (IL‑10) in blood serum.</p></sec><sec><title>Results</title><p>Results. In patients with OSAS, a statistically significant increase in the complex of proatherogenic factors was found: hsCRP, pro-inflammatory cytokines, ratio of apoproteins and atherogenic coefficient compared with patients without OSAS despite the absence of differences in the severity of atherosclerotic lesions of the carotid arteries in these groups</p></sec><sec><title>Conclusion</title><p>Conclusion. The development of OSAS is associated with severe lipid metabolism disorders and activation of nonspecific inflammation, which determines an increased risk of atherosclerosis in this group of patients.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>синдром обструктивного апноэ сна</kwd><kwd>атеросклероз сонных артерий</kwd><kwd>дислипидемия</kwd><kwd>маркеры воспаления</kwd></kwd-group><kwd-group xml:lang="en"><kwd>obstructive sleep apnea syndrome</kwd><kwd>carotid atherosclerosis</kwd><kwd>dyslipidemia</kwd><kwd>inflammatory markers</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Yaggi H.K., Concato J., Kernan W.N. et al. Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med. 2005; 10(353):2034–2041.https://doi. org/10.1056/NEJMoa043104.</mixed-citation><mixed-citation xml:lang="en">Yaggi H.K., Concato J., Kernan W.N. et al. Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med. 2005; 10(353):2034–2041.https://doi. org/10.1056/NEJMoa043104.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Young T., Finn L., Peppard P.E. et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008; 31(8): 1071–1078.</mixed-citation><mixed-citation xml:lang="en">Young T., Finn L., Peppard P.E. et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008; 31(8): 1071–1078.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Altin R., Ozdemir H., Mahmutyazicioglu K. et al. Evaluation of carotid artery wall thickness with high-resolution sonography in obstructive sleep apnea syndrome. J. Clin. Ultrasound. 2005; 33(2): 80–86. https://doi.org/ 10.1002 / jcu.20093.</mixed-citation><mixed-citation xml:lang="en">Altin R., Ozdemir H., Mahmutyazicioglu K. et al. Evaluation of carotid artery wall thickness with high-resolution sonography in obstructive sleep apnea syndrome. J. Clin. Ultrasound. 2005; 33(2): 80–86. https://doi.org/ 10.1002 / jcu.20093.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chen B., Zhang W., Chen Y. et al. Association of obstructive sleep apnea hypopnea syndrome with carotid atherosclerosis and the efficacy of continuous positive airway pressure treatment. Zhonghua Yi Xue Za Zhi. 2015; 95(34): 2791–2795.</mixed-citation><mixed-citation xml:lang="en">Chen B., Zhang W., Chen Y. et al. Association of obstructive sleep apnea hypopnea syndrome with carotid atherosclerosis and the efficacy of continuous positive airway pressure treatment. Zhonghua Yi Xue Za Zhi. 2015; 95(34): 2791–2795.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Meng S., Fang L., Wang C.Q. et al. Impact of obstructive sleep apnoea on clinical characteristics and outcomes in patients with acute coronary syndrome following percutaneous coronary intervention. J. Int. Med. Res. 2009; (37): 1343–1353 https://doi. org/ 10.1177 / 1473–2300–0903–70–05–09.</mixed-citation><mixed-citation xml:lang="en">Meng S., Fang L., Wang C.Q. et al. Impact of obstructive sleep apnoea on clinical characteristics and outcomes in patients with acute coronary syndrome following percutaneous coronary intervention. J. Int. Med. Res. 2009; (37): 1343–1353 https://doi. org/ 10.1177 / 1473–2300–0903–70–05–09.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Drager L. F, Bortolotto L.A., Lorenzi M.C. et al. Early signs of atherosclerosis in obstructive sleep apnea. Amer. J. of Resp. and Crit. Care Med. 2005; 172(5):613–618. https://doi.org/ 10.1164/rccm.200503–340OC.</mixed-citation><mixed-citation xml:lang="en">Drager L. F, Bortolotto L.A., Lorenzi M.C. et al. Early signs of atherosclerosis in obstructive sleep apnea. Amer. J. of Resp. and Crit. Care Med. 2005; 172(5):613–618. https://doi.org/ 10.1164/rccm.200503–340OC.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kim J., Mohler E.R., Keenan B. T. et al. Carotid Artery Wall Thickness in Obese and Nonobese Adults With Obstructive Sleep Apnea Before and Following Positive Airway Pressure Treatment. Sleep. 2017; 40(9). https://doi. org/ 10.1093/sleep/zsx 126.</mixed-citation><mixed-citation xml:lang="en">Kim J., Mohler E.R., Keenan B. T. et al. Carotid Artery Wall Thickness in Obese and Nonobese Adults With Obstructive Sleep Apnea Before and Following Positive Airway Pressure Treatment. Sleep. 2017; 40(9). https://doi. org/ 10.1093/sleep/zsx 126.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bounhoure J.P., Galinier M., Didier A. et al. Sleep apnea syndromes and cardiovascular disease. Bull. Acad. Natl. Med. 2005; 189 (3): 445–459.</mixed-citation><mixed-citation xml:lang="en">Bounhoure J.P., Galinier M., Didier A. et al. Sleep apnea syndromes and cardiovascular disease. Bull. Acad. Natl. Med. 2005; 189 (3): 445–459.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kheirandish-Gozal L., Gozal D. Obstructive Sleep Apnea and Inflammation: Proof of Concept Based on Two Illustrative Cytokines. Int. J. Mol Sci. 2019; 20(3): 459. https://doi. org/ 10.3390/ijms 2003–0459</mixed-citation><mixed-citation xml:lang="en">Kheirandish-Gozal L., Gozal D. Obstructive Sleep Apnea and Inflammation: Proof of Concept Based on Two Illustrative Cytokines. Int. J. Mol Sci. 2019; 20(3): 459. https://doi. org/ 10.3390/ijms 2003–0459</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Taleb S. Inflammation in atherosclerosis. Arch. Cardiovasc. Dis. 2016; 109(12):708– 715. https://doi. org/ 10.1016/j.acvd.2016.04.002.</mixed-citation><mixed-citation xml:lang="en">Taleb S. Inflammation in atherosclerosis. Arch. Cardiovasc. Dis. 2016; 109(12):708– 715. https://doi. org/ 10.1016/j.acvd.2016.04.002.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kaptoge S., Angelantonio Е.D., Pennells L. еt al. The Emerging Risk Factors Collaboration C-reactive protein, fibrinogen, and cardiovascular disease prediction N. Engl. J. Med. 2012; 367(14):1310–20. https://doi.org/ 10.1056/NEJMoa1107477.</mixed-citation><mixed-citation xml:lang="en">Kaptoge S., Angelantonio Е.D., Pennells L. еt al. The Emerging Risk Factors Collaboration C-reactive protein, fibrinogen, and cardiovascular disease prediction N. Engl. J. Med. 2012; 367(14):1310–20. https://doi.org/ 10.1056/NEJMoa1107477.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ammirati E., Moroni F., Norata G.D. et al. Markers of Inflammation Associated with Plaque Progression and Instability in Patients with Carotid Atherosclerosis Mediators of Inflamm. 2015; 2015(718329): 1–15. https://doi.org/ 10.1155/2015/718329.</mixed-citation><mixed-citation xml:lang="en">Ammirati E., Moroni F., Norata G.D. et al. Markers of Inflammation Associated with Plaque Progression and Instability in Patients with Carotid Atherosclerosis Mediators of Inflamm. 2015; 2015(718329): 1–15. https://doi.org/ 10.1155/2015/718329.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Willeit, P.; Thompson, S. G.; Agewall, S. et al. Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration Eur. J. Prev. Cardiol. 2016; 23 (2): 194–205. https://doi.org/ 10.1177/2047–4873–1456–06–64.</mixed-citation><mixed-citation xml:lang="en">Willeit, P.; Thompson, S. G.; Agewall, S. et al. Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration Eur. J. Prev. Cardiol. 2016; 23 (2): 194–205. https://doi.org/ 10.1177/2047–4873–1456–06–64.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Debing E., Peeters E., Demanet C., de Waele M., van den Brande P. Markers of inflammation in patients with symptomatic and asymptomatic carotid artery stenosis: a case-control study. Vasc. and Endovasc. Surg. 2008; 42 (2):122–127. https://doi.org/ 10.1177/1538–5744–0730–74–06</mixed-citation><mixed-citation xml:lang="en">Debing E., Peeters E., Demanet C., de Waele M., van den Brande P. Markers of inflammation in patients with symptomatic and asymptomatic carotid artery stenosis: a case-control study. Vasc. and Endovasc. Surg. 2008; 42 (2):122–127. https://doi.org/ 10.1177/1538–5744–0730–74–06</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Puz P., Lasek-Bal A., Ziaja D. et al. Inflammatory markers in patients with internal carotid artery stenosis. Arch. of Med. Sci. 2013; 9(2):254–260. https://doi.org/ 10.5114/aoms.2013.34533</mixed-citation><mixed-citation xml:lang="en">Puz P., Lasek-Bal A., Ziaja D. et al. Inflammatory markers in patients with internal carotid artery stenosis. Arch. of Med. Sci. 2013; 9(2):254–260. https://doi.org/ 10.5114/aoms.2013.34533</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Chapman C.M. L., Beilby J.P., McQuillan B. M. et al. Monocyte count, but not C-reactive protein or interleukin 6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke. 2004; 35(7):1619–1624. https://doi. org/ 10.1161/01. STR.0000130857.19423.ad.</mixed-citation><mixed-citation xml:lang="en">Chapman C.M. L., Beilby J.P., McQuillan B. M. et al. Monocyte count, but not C-reactive protein or interleukin 6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke. 2004; 35(7):1619–1624. https://doi. org/ 10.1161/01. STR.0000130857.19423.ad.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Dewberry R., Holden H., Crossman D. et al.Interleukin 1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler. Thromb.Vasc. Biol. 2000; (20):2394–2400. https://doi. org/10.1161/01.atv.20.11.2394.</mixed-citation><mixed-citation xml:lang="en">Dewberry R., Holden H., Crossman D. et al.Interleukin 1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler. Thromb.Vasc. Biol. 2000; (20):2394–2400. https://doi. org/10.1161/01.atv.20.11.2394.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Dinarello CA. Interleukin 1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011; 117(14):3720–3732. https://doi. org/ 10.1182/ blood 2010–07–273417.</mixed-citation><mixed-citation xml:lang="en">Dinarello CA. Interleukin 1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011; 117(14):3720–3732. https://doi. org/ 10.1182/ blood 2010–07–273417.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Шмидт Е.В. Классификация сосудистых поражений головного и спинного мозга. Ж. неврологии и психиатрии им. С.С. Корсакова. 1985; 85(9):1281–1288.</mixed-citation><mixed-citation xml:lang="en">Шмидт Е.В. Классификация сосудистых поражений головного и спинного мозга. Ж. неврологии и психиатрии им. С.С. Корсакова. 1985; 85(9):1281–1288.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Berry R. B., Quan S. F., Abreu A. R. et al. for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terinology and Technical Specifications. Version 2.6 Darien, IL: American Academy of Sleep Medicine; 2020 p.94</mixed-citation><mixed-citation xml:lang="en">Berry R. B., Quan S. F., Abreu A. R. et al. for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terinology and Technical Specifications. Version 2.6 Darien, IL: American Academy of Sleep Medicine; 2020 p.94</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sateia M. J. American Academy of Sleep Medicine. International classification of sleep disorders -third edition highlights and modifications. Chest. 2014; 146(5):1387–1394. https://doi. org/ 10.1378/chest.14–0970.</mixed-citation><mixed-citation xml:lang="en">Sateia M. J. American Academy of Sleep Medicine. International classification of sleep disorders -third edition highlights and modifications. Chest. 2014; 146(5):1387–1394. https://doi. org/ 10.1378/chest.14–0970.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sleep –related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999; 22 (5): 667–689.</mixed-citation><mixed-citation xml:lang="en">Sleep –related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999; 22 (5): 667–689.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Куликов В. П.. Основы ультразвукового исследования сосудов. С 235. М. «Видар-М» 2015. 392с.</mixed-citation><mixed-citation xml:lang="en">Kulikov V. P. Fundamentals of ultrasound examination of blood vessels. P 235. M. "Vidar-M" 2015. 392s.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Spence J.D. Measurement of intima-media thickness vs carotid plaque: uses in patient care, genetic research and evaluation of new therapies. Int J. Stroke 2006; 1(4):216–221.https://doi.org/10.1111/j.1747–4949.2006.00068.x.</mixed-citation><mixed-citation xml:lang="en">Spence J.D. Measurement of intima-media thickness vs carotid plaque: uses in patient care, genetic research and evaluation of new therapies. Int J. Stroke 2006; 1(4):216–221.https://doi.org/10.1111/j.1747–4949.2006.00068.x.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Трухачева Н.В. Математическая статистика в медико-биологических исследованиях с применением пакета Statistica.– М.: ГОЭТАР-МЕдиа, 2013.– 384 с.</mixed-citation><mixed-citation xml:lang="en">Trukhacheva N. V. Mathematical statistics in biomedical research using the Statistica package. - M.: GOETAR-MEdia, 2013. - 384 p.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Ren J., Grundy S.M., Liu J., et al. Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-year Chinese Multi-Provincial Cohort Study (CMCS). Atherosclerosis. 2010;211(1):327–332. https://doi.org/10.1016/ j.atherosclerosis.2010.02.020.</mixed-citation><mixed-citation xml:lang="en">Ren J., Grundy S.M., Liu J., et al. Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-year Chinese Multi-Provincial Cohort Study (CMCS). Atherosclerosis. 2010;211(1):327–332. https://doi.org/10.1016/ j.atherosclerosis.2010.02.020.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">McBride P. Triglycerides and risk for coronary artery disease. Curr Atheroscler Rep. 2008; 10(5):386–390. https://doi. org/ 10.1007/s11883–008–0060–9.</mixed-citation><mixed-citation xml:lang="en">McBride P. Triglycerides and risk for coronary artery disease. Curr Atheroscler Rep. 2008; 10(5):386–390. https://doi. org/ 10.1007/s11883–008–0060–9.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Сhambless L.E., Folsom A.R., Davis V. et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987–1998. Am. J. Epidemiol. 2002; 155 (1): 38–47. https://doi. org/ 10.1093/aje/155.1.38.</mixed-citation><mixed-citation xml:lang="en">Сhambless L.E., Folsom A.R., Davis V. et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987–1998. Am. J. Epidemiol. 2002; 155 (1): 38–47. https://doi. org/ 10.1093/aje/155.1.38.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Nadeem R., Harvey M., Singh M. et al. Patients with obstructive sleep apnea display increased carotid intima media: a meta-analysis. Int. J. Vasc. Med. 2013; 2013 (839582):1–8. https://doi. org/ 10.1155/2013/839582.</mixed-citation><mixed-citation xml:lang="en">Nadeem R., Harvey M., Singh M. et al. Patients with obstructive sleep apnea display increased carotid intima media: a meta-analysis. Int. J. Vasc. Med. 2013; 2013 (839582):1–8. https://doi. org/ 10.1155/2013/839582.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang Y.Q., Xue J. S., Xu J. et al. Efficacy of continuous positive airway pressure treatment in treating obstructive sleep apnea hypopnea syndrome associated with carotid arteriosclerosis. Exp. Ther. Med. 2017; 14(6):6176–6182. https://doi. org/ 10.3892/etm.2017.5308.</mixed-citation><mixed-citation xml:lang="en">Jiang Y.Q., Xue J. S., Xu J. et al. Efficacy of continuous positive airway pressure treatment in treating obstructive sleep apnea hypopnea syndrome associated with carotid arteriosclerosis. Exp. Ther. Med. 2017; 14(6):6176–6182. https://doi. org/ 10.3892/etm.2017.5308.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Kundel V., Trivieri M.G., Karakatsanis N.A. et al. Assessment of atherosclerotic plaque activity in patients with sleep apnea using hybrid positron emission tomography/magnetic resonance imaging (PET/MRI): a feasibility study. Sleep Breath. 2018; 22(4):1125–1135. https://doi. org/ 10.1007/s11325–018–1646–2.</mixed-citation><mixed-citation xml:lang="en">Kundel V., Trivieri M.G., Karakatsanis N.A. et al. Assessment of atherosclerotic plaque activity in patients with sleep apnea using hybrid positron emission tomography/magnetic resonance imaging (PET/MRI): a feasibility study. Sleep Breath. 2018; 22(4):1125–1135. https://doi. org/ 10.1007/s11325–018–1646–2.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kylintireas I, Craig S, Nethononda R, Kohler M, Francis J, Choudhury R, Stradling J, Neubauer S. Atherosclerosis and arterial stiffness in obstructive sleep apnea – a cardiovascular magnetic resonance study. Atherosclerosis. 2012; 222(2):483–489. https://doi. org/ 10.1016/j.atherosclerosis.2012.03.036</mixed-citation><mixed-citation xml:lang="en">Kylintireas I, Craig S, Nethononda R, Kohler M, Francis J, Choudhury R, Stradling J, Neubauer S. Atherosclerosis and arterial stiffness in obstructive sleep apnea – a cardiovascular magnetic resonance study. Atherosclerosis. 2012; 222(2):483–489. https://doi. org/ 10.1016/j.atherosclerosis.2012.03.036</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
